Veterinary Vaccine Adjuvants Market Size, Share & Industry Analysis, By Type (Alum and Calcium Salts, Oil Emulsion Adjuvants, Liposomes, and Archaeosomes, Nanoparticles and Mi-croparticles, and Others), By Application (Research, and Commercial), By Route of Admin-istration (Oral, Subcutaneous, Intramuscular, and Others), By Animal Type (Livestock Animal, and Companion Animal) and Regional Forecast, 2020-2027 (Includes COVID-19 Business Impact)

                                          
We have updated Veterinary Vaccine Adjuvants Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Veterinary Vaccine Adjuvants market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Veterinary Vaccine Adjuvants market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Veterinary Vaccine Adjuvants Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Veterinary Vaccine Adjuvants Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Veterinary Vaccine Adjuvants Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Croda International Plc, to Account for Significantly Large Market Share in Terms of Revenue
The global market for Veterinary Vaccine Adjuvants has been segmented into large, medium, and small industry players. Among this cluster, Croda been a key player in developing adjuvants since 1939. Besides, it is the only company to manufacture sterile adjuvants produced by an aseptic process.

Crodas acquisitions and partnerships with other players of the market have helped achieve the dominant position. For instance, in January 2019, Croda International Plc. announced its acquisition of Brenntag Biosector (Biosector). Biosector has extraordinary industry experience as a vaccine adjuvant specialist, with its product portfolio comprising of innovative aluminum and saponin based adjuvants. With the help of this acquisition, the company strengthened its pharmaceutical offerings and have access to an industry renowned product portfolio of adjuvants. Hence, strategic partnerships and innovations in the veterinary vaccines adjuvants market are anticipated to boost the key players revenue in the coming years.

LIST OF KEY COMPANIES PROFILED:

  
Croda International Plc (UK)
  
Zoetis (U.S.)
  
Phibro Animal Health Corporation (U.S)
  
SEPPIC (France)
  
SPI Pharma ( U.S)
  
Bioveta, a.s. (Czechia)
  
Merck & Co., Inc. (U.S)
  
Avanti Polar Lipids, Inc. (U.S)
  
OZ Biosciences (France)
  
InvivoGen (U.S)
  
Others

KEY INDUSTRY DEVELOPMENTS:

February 2019 Merck and Immune Design announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has acquired Immune Design for USD 5.85 per share in cash for an approximate value of USD 300 million. Immune Design has established a unique portfolio of approaches to immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could improve vaccine development.

August 2019 Phibro Animal Health Corporation announced its acquisition of Osprey Biotechnics, Inc. a privately-held developer and marketer of innovative microbial products. This acquisition strengthens Phibros portfolio of nutritional specialty products and provides new opportunities in a fast-growing sector of the animal health industry. Osprey manufactures and markets numerous products for a variety of applications and industries. Osprey also produces the key components for Phibros recently launched Provia Prime„¢ direct-fed microbial product for poultry.

 

REPORT COVERAGE

The veterinary vaccine adjuvants market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading modalities types. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation

 By Type

  
Alum and Calcium Salts
  
Oil Emulsion Adjuvants
  
Liposomes and Archaeosomes
  
Nanoparticles and Microparticles
  
Others

  SEGMENTATION

By Application

  
Research Application
  
Commercial Application

By Route of Administration

  
Oral
  
Subcutaneous
  
Intramuscular
  
Others

By Animal Type

  
Livestock
  
Companion Animals

By Geography

  
North America (the U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, and the Rest of Europe)
  
Asia Pacific (India, Japan, Australia, Southeast Asia, China, and the Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, Rest of Latin America)
  
The Middle East and Africa (GCC, South Africa, Rest of MEA)